Gynaecological sarcomas are a rare but important group of gynaecological tumours. The commonest types are leiomyosarcomas and endometrial stromal sarcomas arising from the uterus. Surgery for all gynaecological sarcomas is carried out by the highly experienced gynaecological oncology team which treats all gynaecological cancers within the North London Cancer Network. Chemotherapy and radiotherapy is given by the sarcoma oncologist, who regularly attends the weekly gynaecological oncology MDT meeting to discuss cases.
I trained in St. Mary's Hospital, London and completed an MD (University of London) in gynaecological oncology researching the genetic basis of endometrial cancers. I am the Clinical Lead for Gynaecological Oncology within UCLH and I am also the lead clinician for paediatric and adolescent gynaecological cancers. I have an interest in the laparoscopic treatment of gynaecological cancers. I am an accredited colposcopist and a member of the British Society of Colposcopists and Cytopathologists. I also belong to the British and European Societies of Gynaecological Oncology.
I underwent undergraduate training at Oxford University and St Thomas Hospital medical school before going on to post graduate obstetric/gynaecology training at St Thomas’, Queen Charlottes and Chelsea, University College and the Whittington Hospitals.
I completed specialist gynaecological cancer training at Barts and the Royal Marsden Hospitals before returning to UCH in 2000. I have RCOG sub-specialist accreditation in gynaecological cancer, colposcopy and minimal access surgery.
2000 – present. Consultant Gynaecological Oncologist UCLH. I am a member of the UCLH Sarcoma MDM.
2001-2007: Lead for Gynae Oncology UCLH and the North London Cancer Network
2008-2011; Clinical divisional director for Womens Health at UCLH.
2009-2016: Lead for colposcopy UCLH
2012-2016: Pathway director for Gynaecology for London Cancer
I am an Honorary Senior Lecturer; with 40 peer reviewed publications, 10 book chapters and co-editor of Pelvic Cancer Surgery: Modern Breakthroughs and Future Advances. I am on the trial management committee for the United Kingdom Collaborative Trial in Ovarian Cancer Screening, and CI for STATEC, researching lymph node surgery in endometrial cancer.
As a gynaecological oncologist, my focus is on the prevention, early detection and comprehensive treatment of gynaecological cancers. Working with charities and the media, I promote public awareness and education. At UCLH, I work within a multidisciplinary team to ensure that patients have an appropriate management pathway from diagnosis on. I carry out complex surgery as appropriate.
I am an honorary senior lecturer and have published over 40 papers and book chapters
Other appointments include
2007-2010 Lead Clinician Gynaecological Oncology MDM UCLH & Tumour Board Chair for the North London Gynaecological cancer network
I am a Professor in Women's Cancer and a Consultant Gynaecological Oncology Surgeon at the University College London (UCL). I am the Head of the Women’s Cancer Department and direct the North London Breast Cancer Partnership and the lead of the ESGO European Network for Translational Research. In 2001, having completed my training in Gynaecology and Obstetrics in Austria, I worked at the Norris Comprehensive Cancer Centre in Los Angeles (USA) and spent three years as the lead clinician and surgeon of a large breast cancer centre before embarking on a career at UCL/UCLH from 2005 where I undertook a sub-speciality training in gynaecological oncology. As part of the Institute for Women's Health at UCL, I have established a research group focusing on the role of early detection, risk prediction and prevention of breast and gynaecological cancers. My group was the first who reported that genes which are reversibly suppressed in stem cells become irreversibly suppressed in cancer by means of DNA methylation and have the potential to diagnose cancer. I am an author on more than 120 papers, contributed to numerous text books and got substantial grant income in the last ten years and have lectured widely on my research and clinical experience in the UK and abroad. In my clinical work as a consultant gynaecological oncology surgeon, my particular interest is in complex radical laparoscopic surgery.
Kết quả xổ số Quảng NamI am the plastic and reconstructive surgery representative sitting on the University College Hospital (UCLH) skin cancer Multi-Disciplinary Team (MDT). Within this service, I hold weekly clinics and operating lists that include reconstruction for skin sarcoma. In addition, I provide plastic and reconstructive surgery services to colorectal, gynaecology and urology MDTs at UCLH that involve complex abdominal wall and perineal reconstruction. My specialist interest in ‘complex wounds’ allows me to use the latest techniques and innovation to achieve the most optimal functional and aesthetic outcomes.
I completed my clinical training at St Bartholomew’s and University College London Hospitals. I completed a PhD at the Institute of Cancer Research and the Royal Marsden Hospital which looked at the genes that predispose patients to prostate cancer.
I now specialise in the treatment of soft tissue and bone sarcomas using chemotherapy and radiotherapy. I have a strong interest in clinical research and am currently in the process of developing a number of new local and national research projects in sarcoma. I teach and lecture regularly in the management of sarcomas.
I am part of the oncology team on the Sarcoma Unit at University College Hospital, and specialize in the systemic treatment of patients with bone and soft tissue sarcomas. I completed my training at the Istituto Nazionale Tumori of Milan and at Dana-Farber Cancer Institute in Boston. During my fellowship at Dana-Farber Cancer Institute I also worked with Dr. Karen Albritton, who at that time was setting up of one of the first AYA (adolescents and young adults) Clinic, as well as the Survivorship Clinic. From 2006 to 2010 I was Associate Physician, Medical Oncology, Istituto Nazionale Tumori, Milan working in the Sarcoma Team. I am on the medical board of the Desmoid Tumor Research Foundation and lead physician for our Unit for the treatment of desmoid-type fibromatosis patient. Also lead physician for our team for patient with Giant Cell Tumor requiring medical treatment. I have a strong interest in early phase clinical trials and am a co-investigator for a number of clinical trials in sarcoma.
I was educated and started my training in Internal Medicine in Greece. I also conducted my PhD at University of Ioannina in angiogenesis and proteolysis in cancer of unknown primary site. I completed my specialist training in Oncology at the Royal Marsden Hospital in London during a 3 years fellowship. I followed an academical career in Aristotle University of Thessaloniki in Greece and I led the Medical Oncology Department during my last year of my stay there. In 2015 I was appointed as a Consultant Medical Oncologist at UCLH and I am exclusively treating patients with bone and soft tissue sarcomas with systemic treatment within the London Sarcoma Service.
I have a strong interest in clinical trials across multiple tumor types and more recently in sarcoma, acting as principal and co-investigator for a number of national and international trials. Since my early days in my career, I was involved in the conduction of early clinical trials both in UK and Greece with novel agents and I have experience in pharmacokinetics and pharmacodynamic models.
I have published more than 100 publications in per reviewed journals in clinical and translational research and I regularly teach and lecture in the management of sarcomas. I also hold an honorary clinical senior lectureship contract with UCL and I contribute to the teaching of the medical students. I am member of several scientific organizations including British sarcoma Group, EORTC Soft Tissue and Bone Sarcoma Group, ESMO, ASCO, HeSMO etc.
I trained in treating sarcomas at the Royal Marsden and Middlesex Hospitals in London, and now specialise exclusively in the treatment of soft tissue and bone sarcomas with chemotherapy and radiotherapy.
Kết quả xổ số Quảng Nam I completed a PhD (University of London) at the Institute of Cancer Research in imaging of tumour hypoxia, and currently I have a strong interest in clinical trials in sarcoma, acting as principal and chief investigator for a number of national and international trials. I am actively involved in coordinating sarcoma research at a national level as a member of the NCRN Sarcoma Clinical Studies Group, and I am also a member of the EORTC Soft Tissue and Bone Sarcoma Group. I regularly teach and lecture on the management of sarcomas.
I am a consultant histopathologist with a special interest in bone and soft tissue tumour: diagnostic aspects and molecular genetics. I have worked in a large tertiary hospital in Sao Paulo, Brazil as a consultant for 12 years before taking the current post at the Royal National Orthopaedic Hospital (RNOH) in 2010. I completed my Ph.D. in 2007 with focus in molecular genetics of sarcomas, and since them my research interest includes molecular aspects in the diagnosis and treatment of sarcomas. I am the clinical lead for Molecular Pathology at the histopathology department at RNOH and Honorary Senior Lecturer at University College London, Cancer Institute.
Kết quả xổ số Quảng NamI am a full time NHS consultant pathologist. I am the lead gynae-onc pathologist at UCLH. I take part in specialist reporting of gynaecological pathology and urological pathology specimens.
Kết quả xổ số Quảng NamI share the gynae oncology work load, which includes the reporting of UCLH pathology specimens, frozen sections as well as London cancer network and referral second opinion cases from UK and abroad . I perform both coroners and hospital postmortems. I regularly supervise and conduct lectures for histopathology trainees, biomedical scientists and medical students. I sit on the pathology specialist training comittee of the London deanery and pathology sub-committe of UCL . I am invovlved in assesing year 3 medical students , Bloomsbury foundation year applicants and national histopathology ST 1 applicants .I sit on the ARCP and OPSE panels to assess the London deanery histopathology trainees. I am part of the London Quality Assurance Team for Cervical Screening. As part of my continued professional development I take part in the gynaecological pathology and urological pathology EQA schemes.
I am the clinical lead for the diagnostic pathology service for the London Sarcoma Service undertaking the NHS service work at the Royal National Orthopaedic Hospital NHS Trust. My research is based in the NHS Histopathology Department in Stanmore, and in the Paul O'Gorman Cancer Institute, Huntley Street, UCL.
Making a correct diagnosis is pivotal in deciding the best treatment for a patient. Cancer is caused by genetic alterations in cells and we can use these genetic changes to diagnose tumours accurately. Over the last 10 years, my research has focused on improving the way that we provide diagnoses for patients. In collaboration with my NHS colleagues we have translated this research into clinical practice and are using our findings every day in clinical practice.
I am a Consultant Histopathologist with a special interest in bone and soft tissue tumours. I completed my histopathology training in Nottingham University Hospitals from 2011-2016 before taking up a post as a Clinical Fellow in bone and soft tissue tumours from August 2016, to develop my knowledge in this area. During my fellowship at RNOH, I have obtained a distinction in the MSc in Genomic Medicine and successfully obtained funding to research MPNST from Health Education England as a Genomics Fellow, in addition to developing my knowledge in the pathology and molecular genetics of sarcoma. I have undertaken lecturing to medical students in non-neoplastic musculoskeletal pathology at the Royal Free Campus of the UCL Medical School. I am now actively working on a collaborative study centred at the Boston Children’s Hospital, as an oncology and pathology representative in the Genomics of MPNST Consortium (GeM) in addition to my clinical commitments. I started as a Consultant Histopathologist at the RNOH from January 2019 as part of the London Sarcoma Service.
I am a full-time histopathologist with exclusive interest in the biology and pathology of bone and soft tissue tumours.